Genmab Genmab is a biotechnology company that develops and commercializes antibody therapeutics to treat cancer. | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | ||
Founding Date | Founding Date 1999 | Founding Date 1904 | Founding Date 1935 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Copenhagen, DK HQ Tokyo, JP Utrecht, NL Plainsboro, US | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more |
Employees | Employees 2,638 | Employees 7,5692% decrease | Employees 27,764 |
Financial | |||
Revenue (est.) | Revenue (est.) $3.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) ₹277.1b (FY, 2026) |
Cost of goods | Cost of goods $221m (FY, 2025) | Cost of goods N/A | Cost of goods ₹95.5b (FY, 2026) |
Gross profit | Gross profit $3.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit ₹195b (FY, 2026) |
Net income | Net income $963m (FY, 2025) | Net income N/A | Net income ₹38.7b (FY, 2026) |
Operating ⚠ | |||
Trademarks | Trademarks 285 (FY, 2018) | Trademarks 4 (Dec, 2020) | Trademarks N/A |

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company